Overdose of Atypical Antipsychotics

  title={Overdose of Atypical Antipsychotics},
  author={Michael Levine and Anne-Michelle Ruha},
  journal={CNS Drugs},
Historically, treatment for schizophrenia focused on sedation. The advent of the typical antipsychotics resulted in treatment aimed specifically at the underlying disease, but these agents were associated with numerous adverse effects, and were not particularly effective at treatment of the negative symptoms of schizophrenia. As a result, numerous atypical agents have been developed over the past 2 decades, including several agents within the past 5 years.Overdose of antipsychotics remains… Expand

Paper Mentions

Interventional Clinical Trial
Intravenous Lipid Emulsion in Improving Coma Of Antipsychotic drugs Acute Poisoning: A Randomized Controlled Trial in Poison Control Center of Ain Shams University Hospitals  
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.
Treatment with lurasidone yields relatively lower risk for developing sedation or overweight/obesity, and in patients with schizophrenia the recommended dose range is 40-80mg/day and in bipolar depression broader dosage ranges were found to be effective. Expand
Forensic Toxicology of Stimulants and Psychotropic Drugs
Psychotropic drugs that have high lethality associated with overdose include typical antipsychotics, tricyclic antidepressants, and barbiturates, and non-benzodiazepines, which are associated with a risk for overdose, increased suicide rates, and onset of discontinuation syndrome. Expand
The Use of Physostigmine in the Diagnosis and Treatment of Anticholinergic Toxicity After Olanzapine Overdose: Literature Review and Case Report.
Physostigmine, a tertiary acetylcholinesterase inhibitor, can be used to assist in the both the diagnosis and management of severe anticholinergic toxicity associated with an olanzapine overdose, which might be applicable to the antimuscarinic toxidrome associated with the ingestion of agents with significant antICHolinergic activity. Expand
Delayed-Onset Seizure in a Mild Quetiapine Overdose: Report of a Case and Review of the Literature
Unique to this case, delayed-onset seizures occurred in a patient with a relatively low dose of quetiapine and no obvious toxidrome, suggesting that this reaction may be an important consideration in the management ofQuetiAPine overdose. Expand
Magnesium in schizophrenia.
Multidirectional activity of magnesium can significantly increase its therapeutic effect in psychiatry, and this observation is confirmed by recent studies conducted by various research teams. Expand
Characterization of intentional lurasidone ingestions using the United States National Poison Data System
Retrospective analysis of single-substance intentional lurasidone ingestions from the National Poison Data System from 2011 to 2018 demonstrates intentional luraidone overdoses reported to poison centers generally have a favorable clinical course. Expand
The systemic inflammatory response syndrome in acute antipsychotic poisoning
The most pronounced correlation is that between the SIRS score, plasma D‐dimer level, and the plasma level of the D‐ dimer derivatives, oligopeptides. Expand
Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability
Data suggest the need to develop a pharmacovigilance monitoring system to evaluate prescription accuracy, long-term safety of ongoing medications, and the fixed doses in this autistic population with associated ID. Expand
B-Type Natriuretic Peptide and Troponin I as Possible Predictive Biomarkers for Cardiotoxicity Induced By Tricyclic Antidepressants and Antipsychotics Overdose
Although unsuitable for screening purposes, BNP surpassed cTnI as a useful tool for the diagnosis of cardiotoxicity due to overdose by tricyclic antidepressants and antipsychotic drugs. Expand
Toxidrome-based Approach to Common Poisonings
The objective of this article is to review the toxidrome-based approach to common poisonings before toxicological analysis enables the confirmation of the initially suspected toxic etiology. Expand


New atypical antipsychotic medications.
The drugs' unique profiles with regard to other side effects may make it possible to tailor treatment more individually to patients, and further refinement of the clinical utility of these drugs awaits their widespread use in mainstream clinical settings. Expand
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
While new atypical antipsychotics medications may have a safer therapeutic and overdose profile than first-generation antipsychotic medications, many adverse and toxic effects still need to be considered in therapeutic monitoring and overdose management. Expand
Recent Advances in the Pharmacotherapy of Schizophrenia
  • R. Borison
  • Psychology, Medicine
  • Harvard review of psychiatry
  • 1997
Pharmacoeconomic studies comparing clozapine and risperidone to the standard neuroleptics indicate that these newer drugs appear likely to lower the overall cost of treatment for schizophrenia, primarily by reducing rates of relapse and rehospitalization. Expand
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
The main features regarding pharmacodynamics, pharmacokinetics and pharmacological interactions of the most important atypical antipsychotic agents, namely clozapine, olanzapines, quetiapine and risperidone, are treated herein. Expand
Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia
The new antipsychotic medications introduced over the last 15 years have shown themselves to be at least comparable in efficacy to conventional antipsychotics but with superior subjective tolerability and a more favourable adverse effect profile. Expand
The Pharmacology and Toxicology of Atypical Antipsychotic Agents
  • M. Burns
  • Medicine
  • Journal of toxicology. Clinical toxicology
  • 2001
The pharmacodynamics, pharmacokinetics, and toxicology of atypical antipsychotic drugs, chiefly clozapine, risperidone, olanzapines, and quetiapine are reviewed and recommendations on management are provided. Expand
Adverse Effects of Atypical Antipsychotics
It is concluded that broad statements comparing the relative risk of specific adverse effects between ‘atypical’ and ‘conventional’ antipsychotics are largely meaningless; rather, comparisons should be made between specific atypical and specific conventional drugs. Expand
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
A systematic literature review of overdoses of atypical antipsychotic medications suggests that overdose of AAPM is unlikely to cause significant cardiovascular toxicity. Expand
A Comparative Review of New Antipsychotics
  • O. Blin
  • Medicine, Psychology
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1999
A decision algorithm for comparing drugs used for psychotic disorders, based on biochemical profile, experimental pharmacology, postiron emission tomography (PET) scan results, and clinical efficacy on positive, negative, anxious, depressive, and cognitive symptoms is proposed. Expand
Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients
No difference regarding re-hospitalization and inpatient-days was found, whether the patient was treated with typical or atypical antipsychotics, however, it is important to underline that patients treated with atypicals oral antipsychotic do as well as patients on typical depot antippsychotics. Expand